CorMedix (CRMD) Form 4 CorMedix / Antony Pfaffle ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Pfaffle Antony

(Last) (First) (Middle)

C/O CORMEDIX INC.

1430 U.S. HIGHWAY 206, SUITE 200

(Street)

BEDMINSTER NJ 07921

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CorMedix Inc. [ CRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Interim Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2016

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.001 par value per share	06/10/2016		M		5,000	A	$0.68	5,000	D
Common Stock, $0.001 par value per share	06/10/2016		S		5,000	D	$2.2812(1)	0	D
Common Stock, $0.001 par value per share	06/13/2016		M		443	A	$0.68	443	D
Common Stock, $0.001 par value per share	06/13/2016		S		443	D	$2.2	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$2.27							(2)	04/01/2024	Common Stock, $0.001 par value per share	100,000		100,000	D
Stock Option (right to buy)	$2.02							(3)	01/09/2024	Common Stock, $0.001 par value per share	100,000		100,000	D
Stock Option (right to buy)	$2.02							(4)	01/09/2024	Common Stock, $0.001 par value per share	30,000		30,000	D
Stock Option (right to buy)	$0.9							(5)	03/22/2023	Common Stock, $0.001 par value per share	210,000		210,000	D
Stock Option (right to buy)	$0.68	06/10/2016		M		5,000		(6)	12/05/2022	Common Stock, $0.001 par value per share	140,000	$0	135,000	D
Stock Option (right to buy)	$0.68	06/13/2016		M		443		(6)	12/05/2022	Common Stock, $0.001 par value per share	135,000	$0	134,557	D
Stock Option (right to buy)	$2.1							(7)	01/14/2021	Common Stock, $0.001 par value per share	30,000		30,000	D
Stock Option (right to buy)	$3.125							(8)	03/30/2020	Common Stock, $0.001 par value per share	20,000		20,000	D
Stock Option (right to buy)	$5							(9)	02/24/2025	Common Stock, $0.001 par value per share	75,000		75,000	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.39, inclusive.

2. The options vested 100% on April 2, 2014.

3. The options vested 100% on January 10, 2014.

4. The options vest in full on the first anniversary of the date of grant.

5. These options vest based on performance milestones running through December 31, 2014.

6. These options vested as follows: (a) fifty percent (50%) on the date of the issuance of the CE mark certification, which occurred on July 5th, 2013, and (b) fifty percent (50%) on December 31, 2013.

7. These options vested on January 14, 2012.

8. These options vested as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012.

9. These options were granted on February 24, 2015, and vested immediately.

Remarks:

	Alexander M. Donaldson, with a Power of Attorney for Antony E. Pfaffle, M.D.	06/14/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.